Pfizer Limited (PFIZER) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Pfizer Limited (PFIZER) has a cash flow conversion efficiency ratio of 0.156x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.99 Billion ≈ $64.83 Million USD) by net assets (Rs38.48 Billion ≈ $416.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Pfizer Limited balance sheet independence to measure how much of total assets are equity-financed.
Pfizer Limited - Cash Flow Conversion Efficiency Trend (2005–2026)
This chart illustrates how Pfizer Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Pfizer Limited (PFIZER) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Pfizer Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pfizer Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China Railway Hi-tech Industry Corp Ltd
SHG:600528
|
0.101x |
|
ACME Solar Holdings Limited
NSE:ACMESOLAR
|
0.151x |
|
Bank of Xi'An Co Ltd
SHG:600928
|
0.403x |
|
eToro Group Ltd.
NASDAQ:ETOR
|
0.076x |
|
Poco Holding Co Ltd
SHE:300811
|
0.018x |
|
KANSAI PAINT SPON.ADR/1/2
F:KAP0
|
N/A |
|
Shanghai Kingstar Winning Software
SHE:300253
|
-0.012x |
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
-0.032x |
Annual Cash Flow Conversion Efficiency for Pfizer Limited (2005–2026)
The table below shows the annual cash flow conversion efficiency of Pfizer Limited from 2005 to 2026. For the full company profile with market capitalisation and key ratios, see Pfizer Limited stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs42.03 Billion ≈ $454.53 Million |
Rs11.44 Billion ≈ $123.67 Million |
0.272x | +73.94% |
| 2025-03-31 | Rs42.17 Billion ≈ $456.10 Million |
Rs6.60 Billion ≈ $71.35 Million |
0.156x | +119.00% |
| 2024-03-31 | Rs35.96 Billion ≈ $388.84 Million |
Rs2.57 Billion ≈ $27.78 Million |
0.071x | -35.59% |
| 2023-03-31 | Rs32.07 Billion ≈ $346.86 Million |
Rs3.56 Billion ≈ $38.47 Million |
0.111x | -52.38% |
| 2022-03-31 | Rs28.64 Billion ≈ $309.78 Million |
Rs6.67 Billion ≈ $72.14 Million |
0.233x | +30.42% |
| 2021-03-31 | Rs23.93 Billion ≈ $258.80 Million |
Rs4.27 Billion ≈ $46.21 Million |
0.179x | +87.62% |
| 2020-03-31 | Rs33.95 Billion ≈ $367.21 Million |
Rs3.23 Billion ≈ $34.95 Million |
0.095x | +193.03% |
| 2019-03-31 | Rs30.11 Billion ≈ $325.66 Million |
Rs978.10 Million ≈ $10.58 Million |
0.032x | -73.73% |
| 2018-03-31 | Rs26.83 Billion ≈ $290.18 Million |
Rs3.32 Billion ≈ $35.88 Million |
0.124x | -9.03% |
| 2017-03-31 | Rs24.19 Billion ≈ $261.59 Million |
Rs3.29 Billion ≈ $35.56 Million |
0.136x | -16.22% |
| 2016-03-31 | Rs21.18 Billion ≈ $229.05 Million |
Rs3.44 Billion ≈ $37.16 Million |
0.162x | +182.10% |
| 2015-03-31 | Rs19.73 Billion ≈ $213.37 Million |
Rs1.13 Billion ≈ $12.27 Million |
0.058x | -71.41% |
| 2014-03-31 | Rs6.58 Billion ≈ $71.20 Million |
Rs1.32 Billion ≈ $14.32 Million |
0.201x | +4060.27% |
| 2013-03-31 | Rs16.94 Billion ≈ $183.25 Million |
Rs-86.07 Million ≈ $-930.79K |
-0.005x | -127.10% |
| 2012-03-31 | Rs13.05 Billion ≈ $141.10 Million |
Rs244.59 Million ≈ $2.65 Million |
0.019x | -86.64% |
| 2011-03-31 | Rs11.63 Billion ≈ $125.82 Million |
Rs1.63 Billion ≈ $17.66 Million |
0.140x | +86.88% |
| 2010-03-31 | Rs9.94 Billion ≈ $107.53 Million |
Rs746.73 Million ≈ $8.08 Million |
0.075x | -71.54% |
| 2009-03-31 | Rs9.01 Billion ≈ $97.45 Million |
Rs2.38 Billion ≈ $25.71 Million |
0.264x | +941.98% |
| 2008-03-31 | Rs6.50 Billion ≈ $70.26 Million |
Rs164.53 Million ≈ $1.78 Million |
0.025x | -90.96% |
| 2007-03-31 | Rs4.40 Billion ≈ $47.56 Million |
Rs1.23 Billion ≈ $13.32 Million |
0.280x | +2.51% |
| 2006-03-31 | Rs3.76 Billion ≈ $40.66 Million |
Rs1.03 Billion ≈ $11.11 Million |
0.273x | +6.40% |
| 2005-03-31 | Rs3.40 Billion ≈ $36.72 Million |
Rs872.08 Million ≈ $9.43 Million |
0.257x | -- |
About Pfizer Limited
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vi… Read more